UK says home-grown cancer pill too costly to use (Reuters)

Reuters – Britain’s health cost watchdog NICE sparked a major row on Thursday by snubbing a pricey new prostate cancer pill discovered at the country’s top cancer research centre, a decision critics said was bad for patients and research.